The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome.
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/36317/ |